About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
G
ESMO 2024 Insights: SOGUG-AUREA Study - Split-Dose Cisplatin and Atezolizumab in Cisplatin-Ineligible Urothelial Carcinoma
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Guillermo de Velasco
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Guillermo de Velasco
24 views
September 23, 2024
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Advanced Prostate Cancer Consensus Conference (APCCC)
APCCC 2026
Fri, Feb 27, 2026
14:16
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…
Feat.
E. Efstathiou
09:55
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…
Feat.
E. Hamilton
16:05
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
Feat.
T. Powles,
B. Rini
20:41
2024 ASCO® Annual Meeting Insights Hub
Bladder Cancer Highlights From ASCO® 2024
Feat.
G. Sonpavde
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
29:25
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
Feat.
Y. Chae
09:14
Robert Dreicer
AUA Advanced Prostate Cancer Guidelines: 2023 Update
21:08
Integrity CE
Updates in the Treatment and Management of Bladder Cancer
Feat.
M. Galsky,
B. Guercio
15:58
Total Health
Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024
Feat.
M. Reimers
03:05
Benjamin L. Maughan
Testosterone Suppression and Recovery in Patients With Advanced Pros…
06:27
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evaluation of Persistence and Adherence f…
Feat.
J. Hafron
22:19
Insights from 2023 ESMO Annual Meeting
Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …
Feat.
G. Sonpavde
22:27
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
Feat.
G. Sonpavde
10:19
University of Colorado Cancer Center
NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…
Feat.
T. Flaig
22:07
Weill Cornell Medicine Oncology & Hematology
Urothelial Carcinoma: New Developments
Feat.
C. Sternberg
17:32
Kriti Mittal
Current Updates in Urothelial Cancer: Clinical Implications for Prac…
15:28
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
Feat.
K. Tawagi,
N. Reizine
14:00
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…
Feat.
G. Sonpavde
09:45
Northwestern Medicine Oncology and Hematology
Differences Between Urologists and Medical Oncologists in the Manage…
Feat.
W. Catalona
09:40
UCSF School of Medicine
Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer
Feat.
V. Koshkin
